Effect of subinhibitory concentrations of antibiotics on the adhesion of Streptococcus pyogenes to pharyngeal epithelial cells.

Antimicrobial Agents and Chemotherapy
S TylewskaT Wadström

Abstract

The hydrophobicity and charge of the cell surface of M protein-positive (M+) and the less virulent M protein-negative (M-) strains of type 12 Streptococcus pyogenes have been studied, respectively, by hydrophobic interaction chromatography and free zone electrophoresis. The M+ strain had a more hydrophobic and a more negatively charged surface than the M- strain. When the M+ strain was cultivated in the presence of sub-minimum inhibitory concentrations of different antibiotics, its hydrophobicity either decreased or did not change. The M+ organisms adhered to pharyngeal epithelial cells more avidly than M+; however, cultivation of both strains with sub-minimum inhibitory concentrations of penicillin and rifampin led to the decrease in adhesion. Tetracycline caused a decrease in adhesion for the M+ strain only, whereas cephalothin and polymyxin (to which the strains are resistant) did not affect adhesion or hydrophobicity of the M+ organisms. The negative surface charge of the M+ bacteria increased considerably upon exposure to rifampin and penicillin, and the M- bacteria exhibited small or no change. The contributions of these changes to suppression of infections are discussed.

References

Oct 1, 1979·The Journal of Infectious Diseases·B Sugarman, S T Donta
Apr 1, 1976·The Journal of Experimental Medicine·E H Beachey, I Ofek
Jan 1, 1974·Infection and Immunity·R P Ellen, R J Gibbons
Mar 1, 1980·The Journal of Antimicrobial Chemotherapy·W H BeggsG A Sarosi

❮ Previous
Next ❯

Citations

Jun 1, 1985·European Journal of Clinical Microbiology·C Lam, E Basalka
Dec 1, 1982·European Journal of Clinical Microbiology·P K Peterson
Nov 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·P C Braga, S Reggio
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·D M Schifferli, E H Beachey
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·D M Schifferli, E H Beachey
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·I Odenholt-TornqvistO Cars
Jul 1, 1993·The American Review of Respiratory Disease·K W TsangR Wilson
Jun 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·S Tylewska, W Hryniewicz
Apr 9, 1998·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·C FallgrenT Wadström
Jan 1, 1985·Journal of Periodontal Research·W J PerosZ Skobe
Sep 1, 1983·Journal of Veterinary Pharmacology and Therapeutics·H Søgaard, J L Larsen
Sep 25, 2008·Revista Do Instituto De Medicina Tropical De São Paulo·Angela Maria Mendes AraújoLeslie C Benchetrit
Feb 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Soheila AbachiH P Vasantha Rupasinghe
Oct 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·T WadströmS Hjertén
Sep 1, 1982·Infection and Immunity·B SugarmanW A Stenback

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.